Ikeda, Masafumi http://orcid.org/0000-0002-4050-2086
Morimoto, Manabu
Tajimi, Masaomi
Inoue, Koichi
Benhadji, Karim A.
Lahn, Michael M. F.
Sakai, Daisuke
Article History
Received: 7 May 2018
Accepted: 4 July 2018
First Online: 11 July 2018
Compliance with ethical standards
:
: Masafumi Ikeda has received honoraria from Bayer Yakuhin and Eisai, has acted in a consultant or advisory role for Bayer Yakuhin and Eisai, and received research funding from Bayer Yakuhin, Bristol Myers-Squibb, Chugai Pharmaceutical, Eisai, Eli Lilly Japan K. K., and Kyowa Hakko Kirin. Karim Benhadji, Koichi Inoue, and Masaomi Tajimi are full-time employees of Eli Lilly and Company. Michael MF Lahn is a previous full-time employee of Eli Lilly and Company and holds stocks in the company. All remaining authors have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the International Conference on Harmonisation Guidelines for Good Clinical Practice, the ethical standards of the institutional and/or national research committee, and the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.